Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations


Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Friday, as follows:

Apple Inc. (NASDAQ:AAPL) analysts reiterated AAPL at outperform with a 220 price objective at Merrill Lynch, calling it a defensive stock to own given derisked expectations, strong cash levels and an incremental capital return plan. It also noted that the market is already pricing in a declining growth in hardware scenario and a worse than run rate trajectory for services revenues. Merrill Lynch’s Northside/Southside scenarios on cash flows are 232 and 141.

Carlyle Group L.P. (NASDAQ:CG) was reiterated as Outperform and the price target was raised to 28 from 27 at Credit Suisse. Oppenheimer maintained its Outperform rating but cut the target price to 35 from 39.

Eaton Corp. PLC (NYSE:ETN) was reiterated as Buy and the price target was raised to 90 from 85 at Argus.

Gilead Sciences Inc. (NASDAQ:GILD)  Citigroup was reiterated its Buy rating and raised its price target to 105 from 103 Thursday.

Humana Inc. (NYSE:HUM) analysts raised to Outperform from Neutral with a 306 price target at Credit Suisse. The firm expects Humana to deliver above-market enrollment growth in Y 2019 after returning to industry level growth in Y 2018. Oppenheimer reiterated its Outperform rating and raised its price target to 305 from 275.

Have a terrific weekend.

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :